AKYA - Akoya Biosciences, Inc.
IEX Last Trade
2.43
-0.030 -1.235%
Share volume: 2,518
Last Updated: Thu 26 Dec 2024 08:29:32 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$2.46
-0.03
-1.22%
Fundamental analysis
22%
Profitability
0%
Dept financing
21%
Liquidity
75%
Performance
30%
Performance
5 Days
2.12%
1 Month
9.55%
3 Months
-11.07%
6 Months
-6.59%
1 Year
-52.47%
2 Year
-76.26%
Key data
Stock price
$2.43
DAY RANGE
$2.39 - $2.46
52 WEEK RANGE
$2.04 - $6.31
52 WEEK CHANGE
-$52.56
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/06/2024
Company detail
CEO: Brian McKelligon
Region: US
Website: akoyabio.com
Employees: 90
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: akoyabio.com
Employees: 90
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Akoya Biosciences provides spatial biology solutions focused on transforming discovery and clinical research. It offers single-cell resolution with spatial context that provides a wealth of information to visualize tissue organization and disease pathology on a molecular level. The company also provides PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition.
Recent news